Covered recipient · General Payments record
ALEXA CALAS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$437.60
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $298.69 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $134.04 | 10 |
| ABBVIE INC. | $79.60 | 3 |
| ARGENX US, INC. | $25.75 | 1 |
| UCB, Inc. | $21.40 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.54 | 1 |
| Genentech USA, Inc. | $18.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.30 | 01/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106864015 | CMS |
| ABBVIE INC. | $20.61 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106864017 | CMS |
| ABBVIE INC. | $29.69 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106864019 | CMS |
| ARGENX US, INC. | $25.75 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142153324 | CMS |
| Genentech USA, Inc. | $18.36 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133138278 | CMS |
| Novartis Pharmaceuticals Corporation | $19.54 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086667905 | CMS |
| PFIZER INC. | $3.22 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131476316 | CMS |
| PFIZER INC. | $13.39 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131160131 | CMS |
| PFIZER INC. | $4.00 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131476312 | CMS |
| PFIZER INC. | $2.93 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131410551 | CMS |
| PFIZER INC. | $21.01 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131405067 | CMS |
| PFIZER INC. | $15.70 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131671105 | CMS |
| PFIZER INC. | $17.17 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131740230 | CMS |
| PFIZER INC. | $19.72 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131976003 | CMS |
| PFIZER INC. | $19.21 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130891087 | CMS |
| PFIZER INC. | $17.69 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131485811 | CMS |
| UCB, Inc. | $21.40 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143390290 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.